Suppr超能文献

纳米制剂:改善帕金森病实验模型中神经保护和神经修复潜力的有效治疗策略。

Nanoformulation: A Useful Therapeutic Strategy for Improving Neuroprotection and the Neurorestorative Potential in Experimental Models of Parkinson's Disease.

机构信息

Laboratory of Clinical and Experimental Neuroscience (LaNCE), University of the Basque Country UPV/EHU, Leioa, Vizcaya, Spain.

Laboratory of Clinical and Experimental Neuroscience (LaNCE), University of the Basque Country UPV/EHU, Leioa, Vizcaya, Spain.

出版信息

Int Rev Neurobiol. 2017;137:99-122. doi: 10.1016/bs.irn.2017.09.003. Epub 2017 Oct 20.

Abstract

Parkinson's disease (PD) is the second most frequent neurodegenerative disorder, but current therapies are only symptomatic. Experimental models are necessary to go deeper in the comprehension of pathophysiological mechanism and to assess new therapeutic strategies. The unilateral 6-hydroxydopamine (6-OHDA) lesion either in medial forebrain bundle (MFB) or into the striatum in rats affords to study various stages of PD depending on the evolution time lapsed. A promising alternative to address the neurodegenerative process is the use of neurotrophic factors; but its clinical use has been limited due to its short half-life and rapid degradation after in vivo administration, along with difficulties for crossing the blood-brain barrier (BBB). Tyrosine hydroxylase (TH) immunostaining revealed a significant decrease of the TH-immunopositive striatal volume in 6-OHDA group from rostral to caudal one. The loss of TH-ir neurons and axodendritic network (ADN) was higher in caudal sections showing a selective vulnerability of the topological distributed dopaminergic system. In addition to a remarkable depletion of dopamine in the nigrostriatal system, the administration of 6-OHDA into MFB induces some other neuropathological changes such as an increase of glial fibrillary acidic protein (GFAP) positive cells in substantia nigra (SN) as well as in striatum. Intrastriatal implantation of micro- or nanosystems delivering neurotrophic factor in parkinsonized rats for bypassing BBB leads to a significative functional and morphological recovery. Neurorestorative morphological changes (preservation of the TH-ir cells and ADN) along the rostrocaudal axis of caudoputamen complex and SN have been probed supporting a selective recovering after the treatment as well. Others innovative therapeutic strategies, such as the intranasal delivery, have been recently assessed in order to search the NTF effects. In addition some others methodological key points are reviewed.

摘要

帕金森病(PD)是第二常见的神经退行性疾病,但目前的治疗方法仅能对症治疗。实验模型对于深入了解病理生理机制和评估新的治疗策略是必要的。单侧 6-羟多巴胺(6-OHDA)损伤无论是在中脑边缘束(MFB)还是纹状体中,都可以根据时间的推移研究 PD 的各个阶段。使用神经营养因子是解决神经退行性过程的一种有前途的替代方法;但由于其半衰期短,体内给药后迅速降解,以及穿过血脑屏障(BBB)的困难,其临床应用受到限制。酪氨酸羟化酶(TH)免疫染色显示,6-OHDA 组从吻侧向尾侧的 TH 免疫阳性纹状体体积显著减少。尾侧节段的 TH-ir 神经元和轴突树突网络(ADN)丢失更高,表现出拓扑分布的多巴胺能系统的选择性脆弱性。除了黑质纹状体系统中多巴胺的明显耗竭外,6-OHDA 注入 MFB 还会引起一些其他神经病理学变化,如黑质(SN)和纹状体中胶质纤维酸性蛋白(GFAP)阳性细胞的增加。向帕金森病大鼠纹状体中植入微或纳米系统以绕过 BBB 来输送神经营养因子会导致显著的功能和形态恢复。在尾侧苍白球复合体和 SN 沿头尾轴进行的神经修复形态变化(TH-ir 细胞和 ADN 的保留)支持治疗后的选择性恢复。最近还评估了其他创新的治疗策略,例如鼻内给药,以寻找 NTF 的作用。此外,还回顾了其他一些关键的方法学要点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验